跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
陳 柏偉
Doctor
內科部
電子郵件
huntershobow
gmail
com
h-index
159
引文
7
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2014
2025
每年研究成果
概覽
指紋
網路
專案
(2)
研究成果
(39)
類似的個人檔案
(6)
指紋
查看啟用 Po-Wei Chen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Acute Coronary Syndrome
46%
Pulmonary Embolism
46%
Percutaneous Coronary Intervention
44%
Cardiovascular System
44%
Coronary Artery Disease
41%
Computer Assisted Tomography
40%
Thrombus
40%
Cardiology
40%
Revascularization
27%
Arteriosclerosis Obliterans
26%
Cerebrovascular Disease
26%
Blood Pressure
26%
Diabetes Mellitus
26%
Primary Prevention
20%
Polystyrenesulfonate Sodium
20%
Clinical Guideline
20%
Hypercholesterolemia
20%
Deep Vein Thrombosis
20%
Hemodialysis
20%
Diabetes
20%
Arteriovenous Fistula
20%
Atherosclerosis
20%
Cardiotoxicity
20%
Ambulatory Blood Pressure
20%
Monotherapy
20%
Platelet
20%
Pulmonary Atresia
20%
Angioplasty
20%
Trastuzumab
20%
Breast Cancer
20%
Heterotopic Ossification
20%
Interventricular Septum
20%
Hypotension
20%
Antiplatelet
20%
Coronary Artery Bypass Graft
20%
Femoral Vein
20%
Dietary Pattern
20%
Thrombotic Thrombocytopenic Purpura
20%
Mean Platelet Volume
20%
Stenting
20%
Patent Ductus Arteriosus
20%
Vitamin D
20%
Muscle Spasm
20%
Health Care
20%
Enhancer Region
13%
Thrombosis
10%
Combination Therapy
10%
Spinal Cord Injury
10%
Fluoroscopy
10%
Quality Improvement
10%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
100%
Monotherapy
60%
Hemodialysis
40%
Antiplatelet
29%
Protein Kinase
26%
Acetylsalicylic Acid
25%
Thrombosis
24%
Diabetes Mellitus
23%
Peripheral Occlusive Artery Disease
22%
Coronary Artery Disease
22%
Clopidogrel
22%
Ticagrelor
22%
Prehypertension
20%
P-Selectin
20%
Thrombotic Thrombocytopenic Purpura
20%
Proprotein Convertase 9
20%
Lung Embolism
20%
Heart Disease
20%
Trastuzumab
20%
Hypotension
20%
Breast Cancer
20%
Chemokine Receptor
20%
Cilostazol
20%
Galectin 3
20%
Thrombus
20%
Coronary Artery Atherosclerosis
20%
Cardiotoxicity
20%
Comorbidity
17%
Low Density Lipoprotein Cholesterol
16%
Cerebrovascular Accident
15%
All Cause Mortality
15%
Combination Therapy
13%
Bleeding
11%
Congestive Heart Failure
11%
Prevalence
10%
Messenger RNA
9%
Heart Infarction
8%
Phosphatase
8%
Adenovirus Vector
8%
Cardiovascular Risk
8%
Thrombin
6%
Deterioration
6%
Artery Thrombosis
6%
Rho Guanine Nucleotide Binding Protein
6%
Rho Kinase Inhibitor
6%
Cardiovascular Disease
6%
Clinical Trial
5%
End Stage Renal Disease
5%
Diseases
5%
Disease Severity
5%
Keyphrases
Sodium Polystyrene Sulfonate
20%
Catheter-directed Thrombolysis
20%
Asia
20%
Aromatase Inhibitors
20%
Manual Compression
20%
Clinical Outcomes
20%
Selective Estrogen Receptor Modulators
20%
Acute Coronary Syndrome
20%
Complex Coronary Artery Disease
20%
Heart Team Approach
20%
Ambulatory Blood Pressure
20%
Occupational Health Care
20%
Treatment Duration
20%
Chronic Thrombus
20%
Access Creation
20%
Aspirin Therapy
20%
Aspirin
20%
P2Y12 Inhibitors
20%
Platelet Volume
20%
Shunt Dysfunction
20%
Femoral Vein Compression
20%
Patients with Breast Cancer
20%
Vaccine-induced Immune Thrombotic Thrombocytopenia
20%
Cardiotoxicity
20%
Ductal Stenting
20%
Mean Platelet Volume
20%
Risk Factor Control
20%
Vitamin D Status
20%
Dual Antiplatelet Therapy Score
20%
Thromboinflammation
20%
Percutaneous Coronary Intervention
13%
Cerebrovascular Accident
11%
Cardiovascular and Cerebrovascular Diseases
11%
Emergency Bronchoscopy
10%
Venous Compression
10%
Technical Failure
8%
Breast Cancer Patients
8%
Acute Thrombus
7%
Blood Pressure Surge
6%
Medical nurses
6%
Blood Pressure Fluctuation
6%
Real Threats
6%
Catheterization Laboratory
6%
Multicenter Trial
6%
Ambulatory Blood Pressure Monitoring
6%
Blood Pressure Changes
6%
U-Net Neural Network
6%
Frontline Clinicians
6%
Dual Antiplatelet Therapy
6%
Major Coronary Events
6%
